Heron Therapeutics
HRTX
HRTX
199 hedge funds and large institutions have $2.33B invested in Heron Therapeutics in 2019 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 78 increasing their positions, 51 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 180 → 199 (+19)
3% more call options, than puts
Call options by funds: $4.93M | Put options by funds: $4.8M
4.56% less ownership
Funds ownership: 114.55% → 109.99% (-4.6%)
Holders
199
Holding in Top 10
3
Calls
$4.93M
Puts
$4.8M
Top Buyers
| 1 | +$47.6M | |
| 2 | +$28.4M | |
| 3 | +$21.2M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$20.6M |
| 5 |
Goldman Sachs
New York
|
+$19.9M |
Top Sellers
| 1 | -$45M | |
| 2 | -$16.6M | |
| 3 | -$11.7M | |
| 4 |
KCM
Kingdon Capital Management
New York
|
-$9.36M |
| 5 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
-$7.39M |